Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery

Recruiting N/A Interventional Study
Epithelial Ovarian Cancer Rectosigmoid Cancer Metastatic
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
Cukurova University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Ovarian cancer is the most common cause of death in gynecological cancer. Approximately 75% of epithelial ovarian cancers are detected at an advanced stage. Metastasis and spread are mostly through transperitoneal planting and neighborhood by shedding from the ovarian surface. Metastasis mostly occurs in the peritoneum, omentum, and intestines. The rectosigmoid colon is the main part of the intest…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Epithelial ovarian cancer * Negative colonoscopy ( no mucosal involvement) * Intraoperative confirmed serosal or seromuscular rectosigmoid infiltration * ECOG \<3 * ASA \<3 Exclusion Criteria: * Nonepithelial ovarian cancers * Rectosigmoid mucosal infiltration * Total or sub…
Contacts

Ghanim Khatib, MD

+903223386060

ghanim.khatib@gmail.com

CONTACT